Inherited fatty acid metabolism disorder
MONDO:0037858A group of genetic disorders that result from the inability to produce or use an enzyme required to oxidize fatty acids, resulting in an inability to generate energy from fatty acid sources.
Also known as: disorder of fatty acid metabolism, fatty acid metabolism disorder, inherited fatty acid metabolism disorder, disorder of fat oxidation, disorders of fatty-acid metabolism
21 clinical trials for this condition and its sub-types, 7 tagged with Inherited fatty acid metabolism disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Inherited fatty acid metabolism disorder
-
Disorder of fatty acid oxidation and ketogenesis 1 trial · 16 incl. sub-types
10 sub-types
- Acyl-CoA dehydrogenase deficiency 0 trials · 12 incl. sub-types Sub-types →
- Carnitine-acylcarnitine translocase deficiency 3 trials
- 3-hydroxy-3-methylglutaric aciduria 1 trial
- 3-hydroxyacyl-CoA dehydrogenase deficiency 1 trial
- Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency 1 trial
- Systemic primary carnitine deficiency disease 1 trial
- Very long chain acyl-CoA dehydrogenase deficiency 1 trial
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency 0 trials
- Acyl-CoA dehydrogenase 9 deficiency 0 trials
- Long chain acyl-CoA dehydrogenase deficiency 0 trials
-
Inherited lipoic acid biosynthesis defect 0 trials · 1 incl. sub-types
6 sub-types
- Pyruvate dehydrogenase E3 deficiency 1 trial
- Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities 0 trials
- Fatal multiple mitochondrial dysfunctions syndrome 0 trials Sub-types →
- Lipoic acid synthetase deficiency 0 trials
- Lipoyl transferase 1 deficiency 0 trials
- Spasticity-ataxia-gait anomalies syndrome 0 trials
Most studied deeper sub-types
-
Heart attack without blockage: trial tests gentler blood thinners for SCAD
Disease control Not yet recruitingThis trial tests whether a less intensive antiplatelet therapy is safer and as effective as standard dual therapy for people with spontaneous coronary artery dissection (SCAD), a rare cause of heart attack in women aged 30–55. Unlike typical heart attacks, SCAD involves a tear in…
Phase 4 • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a breath test replace blood draws for metabolic disease monitoring?
Knowledge-focused Not yet recruitingThis study measures specific substances (metabolites) in the breath and blood of people with inherited metabolic disorders, those on a special ketogenic diet for epilepsy, and healthy volunteers. The goal is to see if a simple breath test can reliably track these metabolites, pot…
Sponsor: University Children's Hospital, Zurich • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC